Related references
Note: Only part of the references are listed.Identification of potent human carbonic anhydrase IX inhibitors: a combination of pharmacophore modeling, 3D-QSAR, virtual screening and molecular dynamics simulations
Varun Chahal et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors
Diaaeldin M. M. Elimam et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors
Heba T. Abdel-Mohsen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Novel 1,3,5-Triazinyl Aminobenzenesulfonamides Incorporating Aminoalcohol, Aminochalcone and Aminostilbene Structural Motifs as Potent Anti-VRE Agents, and Carbonic Anhydrases I, II, VII, IX, and XII Inhibitors
Eva Havrankova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Aromatic Sulfonamides including a Sulfonic Acid Tail: New Membrane Impermeant Carbonic Anhydrase Inhibitors for Targeting Selectively the Cancer-Associated Isoforms
Simone Giovannuzzi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors
Chiara Testa et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms
Wagdy M. Eldehna et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines
Silvia Mussi et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
One-Pot Procedure for the Synthesis of Asymmetric Substituted Ureido Benzene Sulfonamides as Effective Inhibitors of Carbonic Anhydrase Enzymes
Gioele Vannozzi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
One-Pot Procedure for the Synthesis of Asymmetric Substituted Ureido Benzene Sulfonamides as Effective Inhibitors of Carbonic Anhydrase Enzymes
Gioele Vannozzi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Coumarin-Thiourea Hybrids Show Potent Carbonic Anhydrase IX and XIII Inhibitory Action
Pavitra S. Thacker et al.
CHEMMEDCHEM (2021)
Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis
Mohamed A. Abdelrahman et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles
Elias da Silva Santos et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Novel benzenesulfonamides aryl and arylsulfone conjugates adopting tail/dual tail approaches: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies
Assem H. Eldeeb et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors
Claudiu T. Supuran
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)
Carbonic Anhydrase IX Inhibitors as Candidates for Combination Therapy of Solid Tumors
Stanislav Kalinin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Dual Human Carbonic Anhydrase/Cyclooxygenase-2 Inhibitors: A Promising Approach for Cancer Treatment
Mohammad Mahboubi-Rabbani et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)
Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities
Mostafa M. Elbadawi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Inhibition of Carbonic Anhydrase Using SLC-149: Support for a Noncatalytic Function of CAIX in Breast Cancer
Mam Y. Mboge et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors
K. Muni Chandra et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
Metabolic adaptation in hypoxia and cancer
Felipe Paredes et al.
CANCER LETTERS (2021)
Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors
Moataz Shaldam et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Targeting of carbonic anhydrase IX-positive cancer cells by glycine-coated superparamagnetic nanoparticles
Iryna Antal et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2021)
The Carbonic Anhydrase Inhibitor E7070 Sensitizes Glioblastoma Cells to Radio- and Chemotherapy and Reduces Tumor Growth
Silvia A. Teixeira et al.
MOLECULAR NEUROBIOLOGY (2021)
Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors
Shawn C. Chafe et al.
SCIENCE ADVANCES (2021)
Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders
Claudiu T. Supuran
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase
Alessio Nocentini et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives
Rita Meleddu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Benzimidazole derivatives as potent and isoform selective tumor-associated carbonic anhydrase IX/XII inhibitors
Azize Gizem Uslu et al.
BIOORGANIC CHEMISTRY (2020)
Aryl derivatives of 3H-1,2-benzoxathiepine 2,2-dioxide as carbonic anhydrase inhibitors
Aleksandrs Pustenko et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation
Mohamed A. Abdelrahman et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer
Jessica Ruzzolini et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX/XII and of human thioredoxin reductase
Mikhail Krasavin et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors
Aleksandrs Pustenko et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors
Paul C. McDonald et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2020)
X-ray crystallography of Epacadostat in adduct with Carbonic Anhydrase IX
Andrea Angeli et al.
BIOORGANIC CHEMISTRY (2020)
Design, synthesis and biological evaluation of coumarin linked 1,2,4-oxadiazoles as selective carbonic anhydrase IX and XII inhibitors
Pavitra S. Thacker et al.
BIOORGANIC CHEMISTRY (2020)
Tail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes
Vikas Sharma et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IX
Jana Dvoranova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery
Claudiu T. Supuran
EXPERT OPINION ON DRUG DISCOVERY (2020)
Hypoxia-Activated Prodrug Derivatives of Carbonic Anhydrase Inhibitors in Benzenesulfonamide Series: Synthesis and Biological Evaluation
Emilie Anduran et al.
MOLECULES (2020)
Carbonic Anhydrase-IX Guided Albumin Nanoparticles for Hypoxia-mediated Triple-Negative Breast Cancer Cell Killing and Imaging of Patient-derived Tumor
Katyayani Tatiparti et al.
MOLECULES (2020)
Identification of Novel Carbonic Anhydrase IX Inhibitors Using High-Throughput Screening of Pooled Compound Libraries by DNA-Linked Inhibitor Antibody Assay (DIANA)
Jan Tykvart et al.
SLAS DISCOVERY (2020)
Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII
Suleyman Akocak et al.
BIOORGANIC CHEMISTRY (2020)
Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?
Chandra B. Mishra et al.
MEDICINAL RESEARCH REVIEWS (2020)
An overview of carbohydrate-based carbonic anhydrase inhibitors
Doretta Cuffaro et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
Win Topatana et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment
Andrea Angeli et al.
METABOLITES (2020)
Synthesis and biological evaluation of some coumarin hybrids as selective carbonic anhydrase IX and XII inhibitors
Pavitra S. Thacker et al.
BIOORGANIC CHEMISTRY (2020)
A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity
Annachiara Sarnella et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The structural basis for the selectivity of sulfonamido dicarbaboranes toward cancer-associated carbonic anhydrase IX
Michael Kugler et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells
Silvia Peppicelli et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents
Mikhail Krasavin et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors
Adel S. El-Azab et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Novel 8-Substituted Coumarins That Selectively Inhibit Human Carbonic Anhydrase IX and XII
Kerem Buran et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Carbonic anhydrase-IX inhibition enhances the efficacy of hexokinase II inhibitor for hepatocellular carcinoma in a murine model
Eun Ju Cho et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2019)
Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells
Ismail Koyuncu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Design, synthesis and biological evaluation of coumarin-3-carboxamides as selective carbonic anhydrase IX and XII inhibitors
Pavitra S. Thacker et al.
BIOORGANIC CHEMISTRY (2019)
The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond
Silvia Pastorekova et al.
CANCER AND METASTASIS REVIEWS (2019)
Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia
Paul C. McDonald et al.
GASTROENTEROLOGY (2019)
Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
Shawn C. Chafe et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Extracellular Acidosis Modulates the Expression of Epithelial-Mesenchymal Transition (EMT) Markers and Adhesion of Epithelial and Tumor Cells
Anne Riemann et al.
NEOPLASIA (2019)
Carbonic anhydrase 9 confers resistance to ferroptosis/apoptosis in malignant mesothelioma under hypoxia
Zan Li et al.
REDOX BIOLOGY (2019)
New power of self-assembling carbonic anhydrase inhibitor: Short peptide-constructed nanofibers inspire hypoxic cancer therapy
Jiayang Li et al.
SCIENCE ADVANCES (2019)
The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy
Elena Andreucci et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Preclinical Evaluation of Ureidosulfamate Carbonic Anhydrase IX/XII Inhibitors in the Treatment of Cancers
Kaye J. Williams et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Selenols: a new class of carbonic anhydrase inhibitors
Andrea Angeli et al.
CHEMICAL COMMUNICATIONS (2019)
Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer
Jennifer L. Bryant et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
pH-Sensitive Multiligand Gold Nanoplatform Targeting Carbonic Anhydrase IX Enhances the Delivery of Doxorubicin to Hypoxic Tumor Spheroids and Overcomes the Hypoxia-Induced Chemoresistance
Ahmed M. Shabana et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice
Xinxin Song et al.
GASTROENTEROLOGY (2018)
An inhibitory antibody targeting carbonic anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo
Bettina von Neubeck et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
The cytotoxic, apoptotic and oxidative effects of carbonic anhydrase IX inhibitor on colorectal cancer cells
Yasin Tuluce et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2018)
Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis
Samuele Cazzamalli et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one
Claudiu T. Supuran et al.
MEDICINAL RESEARCH REVIEWS (2018)
Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site
Srishti Singh et al.
MOLECULES (2018)
Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme
Bulent Cetin et al.
NEUROPATHOLOGY (2018)
Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity
Anne Riemann et al.
ONCOLOGY RESEARCH (2018)
Sweet Binders: Carbonic Anhydrase IX in Complex with Sucralose
Carrie L. Lomelino et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Systems analysis of intracellular pH vulnerabilities for cancer therapy
Erez Persi et al.
NATURE COMMUNICATIONS (2018)
Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors
Claudiu T. Supuran
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition
Mam Y. Mboge et al.
PLOS ONE (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Genetic ablation of carbonic anhydrase IX disrupts gastric barrier function via claudin-18 downregulation and acid backflux
T. Li et al.
ACTA PHYSIOLOGICA (2018)
Coordinated Regulation of Metabolic Transporters and Migration/Invasion by Carbonic Anhydrase IX
Paul C. McDonald et al.
METABOLITES (2018)
Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness
Carol Ward et al.
METABOLITES (2018)
Carbonic anhydrase XII functions in health and disease
Abdul Waheed et al.
GENE (2017)
Epigenetic determinants of metastasis
Saroor A. Patel et al.
MOLECULAR ONCOLOGY (2017)
The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion
M. Swayampakula et al.
ONCOGENE (2017)
Targeting pH regulating proteins for cancer therapy-Progress and limitations
Scott K. Parks et al.
SEMINARS IN CANCER BIOLOGY (2017)
RNAi-mediated knockdown of CAICAIX enhances the radiosensitivity of nasopharyngeal carcinoma cell line, CNE-2
Liji Jiang et al.
ONCOTARGETS AND THERAPY (2017)
Discovery of New Sulfonamide Carbonic Anhydrase IX Inhibitors Incorporating Nitrogenous Bases
Alessi Nocentini et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Lactate stimulates CA IX expression in normoxic cancer cells
Elena Panisova et al.
ONCOTARGET (2017)
Combination therapy in combating cancer
Reza Bayat Mokhtari et al.
ONCOTARGET (2017)
Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma The ARISER Randomized Clinical Trial
Karim Chamie et al.
JAMA ONCOLOGY (2017)
Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy
Mohammad Reza Asgharzadeh et al.
BIOIMPACTS (2017)
Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo
Nathaniel H. Boyd et al.
JCI INSIGHT (2017)
Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy
Adam C. Palmer et al.
CELL (2017)
Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells
Elina Zandberga et al.
CANCER BIOLOGY & THERAPY (2017)
Tumour acidosis: from the passenger to the driver's seat
Cyril Corbet et al.
NATURE REVIEWS CANCER (2017)
Glutamine Metabolism in Cancer: Understanding the Heterogeneity
Ahmad A. Cluntun et al.
TRENDS IN CANCER (2017)
Sulfamate inhibitor S4 influences carbonic anhydrase IX ectodomain shedding in colorectal carcinoma cells
Helga Helseth Hektoen et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia
Narges K. Tafreshi et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Structure and function of carbonic anhydrases
Claudiu T. Supuran
BIOCHEMICAL JOURNAL (2016)
Hypoxia Potentiates the Radiation-Sensitizing Effect of Olaparib in Human Non-Small Cell Lung Cancer Xenografts by Contextual Synthetic Lethality
Yanyan Jiang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells
Cristina Federici et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models
Derek P. Logsdon et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Cancer: fundamentals behind pH targeting and the double-edged approach
Tomas Koltai
ONCOTARGETS AND THERAPY (2016)
Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas
Vera Miranda-Goncalves et al.
ONCOTARGET (2016)
Is carbonic anhydrase IX a validated target for molecular imaging of cancer and hypoxia?
Jianbo Li et al.
FUTURE ONCOLOGY (2015)
Targeting Carbonic Anhydrase IX Activity and Expression
Brian P. Mahon et al.
MOLECULES (2015)
Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use
Jaromir Pastorek et al.
SEMINARS IN CANCER BIOLOGY (2015)
Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models
Carol Ward et al.
ONCOTARGET (2015)
Hypoxia-induced carbonic anhydrase IX facilitates lactate flux in human breast cancer cells by non-catalytic function
Somayeh Jamali et al.
SCIENTIFIC REPORTS (2015)
Probing the Surface of Human Carbonic Anhydrase for Clues towards the Design of Isoform Specific Inhibitors
Melissa A. Pinard et al.
BIOMED RESEARCH INTERNATIONAL (2015)
The role of membrane acid/base transporters and carbonic anhydrases for cellular pH and metabolic processes
Joachim W. Deitmer et al.
FRONTIERS IN NEUROSCIENCE (2015)
In Vivo Loss of Function Screening Reveals Carbonic Anhydrase IX as a Key Modulator of Tumor Initiating Potential in Primary Pancreatic Tumors
Nabendu Pore et al.
NEOPLASIA (2015)
The Potential of Liposomes with Carbonic Anhydrase IX to Deliver Anticancer Ingredients to Cancer Cells in Vivo
Huei Leng Helena Ng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
Erik O. Pettersen et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2015)
A Small-Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing Tumors
Nikolaus Krall et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Monoclonal antibody G250 targeting CA IX: Binding specificity, internalization and therapeutic effects in a non-renal cancer model
Miriam Zatovicova et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Monoclonal antibodies raised against 167-180 aa sequence of human carbonic anhydrase XII inhibit its enzymatic activity
Dovile Dekaminaviciute et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Cyclic Secondary Sulfonamides: Unusually Good Inhibitors of Cancer-Related Carbonic Anhydrase Enzymes
Janina Moeker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Tumor Microenvironmental Changes Induced by the Sulfamate Carbonic Anhydrase IX Inhibitor S4 in a Laryngeal Tumor Model
Tineke W. H. Meijer et al.
PLOS ONE (2014)
The usefulness of three-dimensional cell culture in induction of cancer stem cells from esophageal squamous cell carcinoma cell lines
Daisuke Fujiwara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
MAPK and PI3K pathways regulate hypoxia-induced atrial natriuretic peptide secretion by controlling HIF-1 alpha expression in beating rabbit atria
Qiu-li Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Glycosidic carbonic anhydrase IX inhibitors: A sweet approach against cancer
Jean-Yves Winum et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Structure, function and applications of carbonic anhydrase isozymes
Md Imtaiyaz Hassan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
The potential of hypoxia markers as target for breast molecular imaging - a systematic review and meta-analysis of human marker expression
Arthur Adams et al.
BMC CANCER (2013)
Antitumor Efficacy of a Monoclonal Antibody That Inhibits the Activity of Cancer-Associated Carbonic Anhydrase XII
Gabor Gondi et al.
CANCER RESEARCH (2013)
Carbonic anhydrase IX from cancer-associated ibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells
Tania Fiaschi et al.
CELL CYCLE (2013)
Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity
Margaret J. Currie et al.
HUMAN PATHOLOGY (2013)
Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells in vitro
Roben G. Gieling et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)
Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer
Peter J. Ratcliffe
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche
F. E. Lock et al.
ONCOGENE (2013)
Suppression of carbonic anhydrase IX leads to aberrant focal adhesion and decreased invasion of tumor cells
Peter Radvak et al.
ONCOLOGY REPORTS (2013)
The effect of carbonic anhydrase IX on focal contacts during cell spreading and migration
Lucia Csaderova et al.
FRONTIERS IN PHYSIOLOGY (2013)
pH sensing and regulation in cancer
Mehdi Damaghi et al.
FRONTIERS IN PHYSIOLOGY (2013)
Knock-down of hypoxia-induced carbonic anhydrases IX and XII radiosensitizes tumor cells by increasing intracellular acidosis
Jerome Doyen et al.
FRONTIERS IN ONCOLOGY (2013)
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
Vincenzo Alterio et al.
CHEMICAL REVIEWS (2012)
Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy
Alan McIntyre et al.
CLINICAL CANCER RESEARCH (2012)
Antimetastatic Effect of Sulfamate Carbonic Anhydrase IX Inhibitors in Breast Carcinoma Xenografts
Roben G. Gieling et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Therapeutic Mechanism and Efficacy of the Antibody-Drug Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9
Heike M. Petrul et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Function of carbonic anhydrase IX in glioblastoma multiforme
Martin A. Proescholdt et al.
NEURO-ONCOLOGY (2012)
Brain phenotype of carbonic anhydrase IX-deficient mice
Pei-wen Pan et al.
TRANSGENIC RESEARCH (2012)
Intercellular adhesion: mechanisms for growth and metastasis of epithelial cancers
Eric M. Balzer et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2012)
Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
Paul C. McDonald et al.
ONCOTARGET (2012)
Selection of Carbonic Anhydrase IX Inhibitors from One Million DNA-Encoded Compounds
Fabian Buller et al.
ACS CHEMICAL BIOLOGY (2011)
Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII
Christina Battke et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Phosphorylation of Carbonic Anhydrase IX Controls Its Ability to Mediate Extracellular Acidification in Hypoxic Tumors
Peter Ditte et al.
CANCER RESEARCH (2011)
Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors
Yuanmei Lou et al.
CANCER RESEARCH (2011)
Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis
Marius I. Ilie et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion
Hye-Jin Shin et al.
JOURNAL OF CELL SCIENCE (2011)
Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis
Fabio Pacchiano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
Jonathan W. Wojtkowiak et al.
MOLECULAR PHARMACEUTICS (2011)
Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer
Abderrahim El Guerrab et al.
PLOS ONE (2011)
Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation
Ludwig Dubois et al.
RADIOTHERAPY AND ONCOLOGY (2011)
A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREXA®) and interferon-alpha-2a in metastatic renal cell carcinoma patients
M. Siebels et al.
WORLD JOURNAL OF UROLOGY (2011)
Dysregulated pH: a perfect storm for cancer progression
Bradley A. Webb et al.
NATURE REVIEWS CANCER (2011)
Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target
Giuseppina De Simone et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis
Kristiina Nordfors et al.
BMC CANCER (2010)
Modulation of Carbonic Anhydrase 9 (CA9) in Human Brain Cancer
Harun M. Said et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Carbonic Anhydrase IX as an Anticancer Therapy Target: Preclinical Evaluation of Internalizing Monoclonal Antibody Directed to Catalytic Domain
M. Zatovicova et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy
Alexander B. Stillebroer et al.
EUROPEAN UROLOGY (2010)
Selective Inhibition of Carbonic Anhydrase IX Decreases Cell Proliferation and Induces Ceramide-Mediated Apoptosis in Human Cancer Cells
Fabio Cianchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Arnold J. Levine et al.
SCIENCE (2010)
The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian α-carbonic anhydrase isoforms
Seppo Parkkila et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives
Julia K. J. Ahlskog et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH
Johanna Chiche et al.
CANCER RESEARCH (2009)
HIF-1 is induced via EGFR activation and mediates resistance to anoikis-like cell death under lipid rafts/caveolae-disrupting stress
Seong-Hee Lee et al.
CARCINOGENESIS (2009)
Intact intracellular tail is critical for proper functioning of the tumor-associated, hypoxia-regulated carbonic anhydrase IX
Alzbeta Hulikova et al.
FEBS LETTERS (2009)
Cyclooxygenase-2/carbonic anhydrase-IX up-regulation promotes invasive potential and hypoxia survival in colorectal cancer cells
Pasquale Sansone et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Generating specificity and diversity in the transcriptional response to hypoxia
Urban Lendahl et al.
NATURE REVIEWS GENETICS (2009)
Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1α levels contribute to emergence of an aggressive phenotype in prostate cancer
L. Khandrika et al.
ONCOGENE (2009)
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
William G. Kaelin et al.
MOLECULAR CELL (2008)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Molecular Origins of Cancer Molecular Basis of Metastasis
Anne C. Chiang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Carbonic anhydrase inhibitors. Interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: Kinetic and X-ray crystallographic studies
Claudia Temperini et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Genetic determinants of cancer metastasis
Don X. Nguyen et al.
NATURE REVIEWS GENETICS (2007)
Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours
P. Hynninen et al.
HISTOPATHOLOGY (2006)
Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1α signal pathways increases resistance to apoptosis by up-regulating survivin gene expression
Xiang-Hong Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Carbonic anhydrase IX expression and tumor oxygenation status do not correlate at the microregional level in locally-advanced cancers of the uterine cervix
A Mayer et al.
CLINICAL CANCER RESEARCH (2005)
Hypoxia-induced dedifferentiation of tumor cells -: A mechanism behind heterogeneity and aggressiveness of solid tumors
H Axelson et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2005)
Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer
K Smith et al.
CANCER RESEARCH (2005)
A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients
I Bleumer et al.
BRITISH JOURNAL OF CANCER (2004)
Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: New pharmacological opportunities due to related binding site recognition
A Weber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion
N Robertson et al.
CANCER RESEARCH (2004)
CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion
LYW Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors
JY Winum et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300
NL Sang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides
D Vullo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin
E Svastova et al.
EXPERIMENTAL CELL RESEARCH (2003)
Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9
MO Gut et al.
GASTROENTEROLOGY (2002)
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma
SK Chia et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration
LYW Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
